EP3397244
TREATMENT OF BREAST CANCER USING A COMBINATION OF A CATIONIC LIPOSOMAL FORMULATION OF TAXANE, A NON-LIPOSOMAL FORMULATION OF TAXANE AND A FURTHER ACTIVE AGENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.12.2016EP published:
6.10.2021EP application number:
16881378.0
EPO information:
European Patent Register
Max expiry date:
27.12.2036
Title:
TREATMENT OF BREAST CANCER USING A COMBINATION OF A CATIONIC LIPOSOMAL FORMULATION OF TAXANE, A NON-LIPOSOMAL FORMULATION OF TAXANE AND A FURTHER ACTIVE AGENT
Timeline
Today
28.12.2016EP application
6.10.2021EP Publication
Owner
Name:
Syncore Biotechnology Co., Ltd.Address:
No. 84, Zhongshan Rd. Dongshan Township, Yilan County 26944, TW
Name:
Cancap Pharmaceutical Ltd.Address:
Unit 180, 13111 Vanier Place, Richmond, British Columbia, CA
Inventor
Name:
LIN, Sih-TingAddress:
Taipei City 110, TW
Name:
TSENG, Hui-YuanAddress:
Taipei City 110, TW
Name:
TENG, Hsin-WeiAddress:
Taipei City 110, TW
Priority
Number:
201562272772 PDate:
30.12.2015Country:
US
Classification
Categories:
A61K 9/127, A61K 31/337, A61K 31/7068, A61K 47/18, A61K 47/24, A61P 35/00, C07D 305/14, C07H 19/06, C07H 19/073, A61K 45/06, A61K 9/00